Last edition
News about "India Business Excellence Fund"
Symbiotec Pharmalab Files Draft Papers to Raise INR 2,180 Crore via IPO
Symbiotec Pharmalab Ltd has filed draft red herring prospectus papers with the Securities and Exchange Board of India to raise INR 2,180 crore through an initial public offering.
India Business Excellence Fund | 20/12/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members